<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE329nnn/GSE329894/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Other</omics_type><species>Escherichia coli</species><gds_type>Other</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE329894</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Coordinated synthesis of double-stranded DNA by a dual reverse transcriptase immune system [Tn-seq]</name><description>Recent studies have revealed that defense-associated reverse transcriptase (DRT) systems mediate antiviral immunity through distinct modes of cDNA synthesis. Class I DRTs catalyze untemplated DNA synthesis with random or nucleotide-biased sequences, whereas Class II DRTs polymerize noncoding RNA-templated products, including concatemeric repeats and homopolymeric cDNA. However, how these distinct modes of cDNA synthesis are employed to drive antiviral defense remains poorly understood. Here, we report a distinctive mechanism of DRT3 immunity, in which RT enzymes from both Class I and Class II coordinate their diverse activities to produce self-complementary double-stranded DNA (dsDNA). Remarkably, whereas the DRT3a enzyme relies on a 5′-ACACAC-3′ RNA template to synthesize long poly-(dTdG) repeats, DRT3b synthesizes precise poly-(dCdA) repeats without any nucleic acid template at all. The cryo-electron microscopy structure reveals that DRT3b assembles into a hexameric complex and employs active site-adjacent residues to function as deoxyadenosine and deoxycytidine gates that enforce alternating addition to produce dinucleotide repeats, representing a unique example of amino acid-templated DNA polymerization. Strikingly, DRT3 immune systems are toxic in a genetic background lacking E. coli RecBCD, implicating host recombination machinery in limiting DRT3-mediated dsDNA levels. Consistent with this model, we discovered that the phage-encoded RecBCD inhibitor, Gam, potently triggers DRT3-mediated abortive infection. Collectively, our findings reveal how two polymerases with distinct templating strategies cooperate to generate complementary DNA and drive antiviral defense.</description><dates><publication>2026/06/22</publication></dates><accession>GSE329894</accession><cross_references><GSM>GSM9712830</GSM><GSM>GSM9712831</GSM><GSM>GSM9712820</GSM><GSM>GSM9712832</GSM><GSM>GSM9712821</GSM><GSM>GSM9712833</GSM><GSM>GSM9712822</GSM><GSM>GSM9712834</GSM><GSM>GSM9712823</GSM><GSM>GSM9712835</GSM><GSM>GSM9712824</GSM><GSM>GSM9712825</GSM><GSM>GSM9712836</GSM><GSM>GSM9712837</GSM><GSM>GSM9712826</GSM><GSM>GSM9712838</GSM><GSM>GSM9712827</GSM><GSM>GSM9712828</GSM><GSM>GSM9712829</GSM><GSM>GSM9712819</GSM><GPL>35738</GPL><GSE>329894</GSE><taxon>Escherichia coli</taxon></cross_references></HashMap>